Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
In aftermath of lead drug implosion, ObsEva's restructuring claims 70% of its staffers — reaching into the C-suite
3 years ago
Verily hooks $1B round amid C-suite shuffle
3 years ago
Financing
Pharma
Biden turns to biotech for his inaugural ARPA-H director
3 years ago
FDA+
Here's your invitation to this year's Endpoints 11 awards. Let's celebrate the best of biotech together
3 years ago
'Conflicts of interest': SEC charges Perceptive Advisors over SPAC dealings, settles for $1.5M penalty
3 years ago
Law
Pfizer reshuffles top leadership to hone commercial strategy, leaving room for new rare disease chief
3 years ago
Pharma
As Fiona Marshall makes her move to NIBR, Merck is ready with a key replacement player
3 years ago
R&D
Ginkgo Bioworks appoints a veteran as its new SVP of biopharma manufacturing
3 years ago
Manufacturing
One week after Takeda walked away, Finch faces second round of layoffs, pipeline pruning
3 years ago
R&D
Updated: AstraZeneca wins last-minute injunction to temporarily stop former exec from starting GSK job
3 years ago
Pharma
MorphoSys woos Merck KGaA vet to lead late-stage push for blockbuster prospect
3 years ago
NIBR chief Jay Bradner joins the exodus at Novartis, handing the keys to Fiona Marshall
3 years ago
‘Shareholders deserve better’: Mereo lays off employees, pushes back against lead stakeholder's shakeup proposals
3 years ago
Pfizer picks up first chief marketing officer from big tech Alphabet’s Verily
3 years ago
Pharma
Marketing
Trapped in Nasdaq’s biotech basement, Codiak’s Doug Williams lays out a survival plan: chopping jobs, PhII plans
3 years ago
R&D
Illumina taps tennis star Chris Evert for its first genomics forum alongside Barack Obama and Bill Gates
3 years ago
Pharma
Marketing
#ESC22: In return to ‘big chronic diseases,’ Europe’s cardio confab showcases mixed bag of data drops
3 years ago
R&D
After China Trodelvy OK, Everest Medicines CEO resigns and the hunt is on for his replacement
3 years ago
Aeglea replaces CEO as company is set to cut more employees, change strategy
3 years ago
Moderna co-founder, ex-Bayer CEO jump aboard Belgian RNA biotech, investing in Series B round
3 years ago
Financing
PACT Pharma suspends sole clinical trial
3 years ago
Pharma
Two decentralized trials startups prove they're not immune to broader wave of biotech layoffs
3 years ago
Bluebird’s regulatory chief departs two days after historic gene therapy nod to join Flagship’s Tessera
3 years ago
Atara set to lay off 77 in California as company seeks to reduce cash burn, transition into new phase
3 years ago
First page
Previous page
38
39
40
41
42
43
44
Next page
Last page